These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6519157)

  • 1. The pharmacokinetics of a new radiosensitiser, Ro 03-8799 in humans.
    Allen JG; Dische S; Lenox-Smith I; Malcolm SL; Saunders MI
    Eur J Clin Pharmacol; 1984; 27(4):483-9. PubMed ID: 6519157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of hypoxic cell radiosensitizers: a review.
    Workman P
    Cancer Clin Trials; 1980; 3(3):237-51. PubMed ID: 7438321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desmethylmisonidazole (Ro 05-9963): clinical pharmacokinetics after multiple oral administration.
    Stratford MR; Minchinton AI; Dische S; Saunders MI; Anderson P
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):377-9. PubMed ID: 7107355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the tumour concentrations obtainable with misonidazole and Ro 03-8799.
    Dische S; Saunders MI; Bennett MH; Dunphy EP; Des Rochers C; Stratford MR; Minchinton AI; Wardman P
    Br J Radiol; 1986 Sep; 59(705):911-7. PubMed ID: 3756388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-performance liquid chromatographic analysis of the new hypoxic cell radiosensitiser, Ro 03-8799, in biological samples.
    Malcolm SL; Lee A; Groves JK
    J Chromatogr; 1983 Apr; 273(2):327-33. PubMed ID: 6863447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical testing of Ro 03-8799--pharmacokinetics, toxicology, tissue and tumor concentrations.
    Saunders MI; Anderson PJ; Bennett MH; Dische S; Minchinton A; Stratford MR; Tothill M
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1759-63. PubMed ID: 6480459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The radiosensitizer Ro 03-8799 and the concentrations which may be achieved in human tumours: a preliminary study.
    Saunders MI; Dische S; Fermont D; Bishop A; Lenox-Smith I; Allen JG; Malcolm SL
    Br J Cancer; 1982 Nov; 46(5):706-10. PubMed ID: 7171452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase I study of the combination of two hypoxic cell radiosensitizers, Ro 03-8799 and SR-2508: toxicity and pharmacokinetics.
    Newman HF; Bleehen NM; Workman P
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1113-6. PubMed ID: 2943709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the fate of misonidazole (RO 07-0582) and its metabolite desmethylmisonidazole (RO 05-9963), two hypoxic cell radiosensitizers: penetration properties in tumor bearing rats.
    Akel G; Canal P; Mockey E; Vandevoorde E; Laurent F; Soula G
    J Pharmacol; 1983; 14(1):67-77. PubMed ID: 6834852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of the hypoxic radiosensitizers misonidazole and demethylmisonidazole after intraperitoneal administration in humans.
    Gianni L; Jenkins JF; Greene RF; Lichter AS; Myers CE; Collins JM
    Cancer Res; 1983 Feb; 43(2):913-6. PubMed ID: 6848201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic considerations in testing hypoxic cell radiosensitizers in mouse tumours.
    Brown JM; Yu NY; Workman P
    Br J Cancer; 1979 Mar; 39(3):310-20. PubMed ID: 465300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentrations achieved in human tumors after administration of misonidazole, SR-2508 and Ro 03-8799.
    Dische S; Saunders MI; Dunphy EP; Bennett MH; Des Rochers C; Stratford MR; Minchinton AI; Orchard RA
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1109-11. PubMed ID: 2943708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacokinetics in mice and dogs of nitroimidazole radiosensitizers and chemosensitizers more lipophilic than misonidazole.
    White R; Workman P; Owen L
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):473-6. PubMed ID: 7107369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pretreatment with phenobarbitone and phenytoin on the pharmacokinetics and toxicity of phenytoin on the pharmacokinetics and toxicity of misonidazole in mice.
    Workman P
    Br J Cancer; 1979 Sep; 40(3):335-53. PubMed ID: 508562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacokinetics and tumor and neural tissue penetrating properties of SR-2508 and SR-2555 in the dog--hydrophilic radiosensitizers potentially less toxic than misonidazole.
    White RA; Workman P; Brown JM
    Radiat Res; 1980 Dec; 84(3):542-61. PubMed ID: 6450431
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetic and metabolic studies of the hypoxic cell radiosensitizer misonidazole.
    Flockhart IR; Large P; Troup D; Malcolm SL; Marten TR
    Xenobiotica; 1978 Feb; 8(2):97-105. PubMed ID: 415443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical testing of the radiosensitiser Ro-07-0582. II. Radiosensitisation of normal and hypoxic skin.
    Dische S; Gray AJ; Zanelli GD
    Clin Radiol; 1976 Apr; 27(2):159-66. PubMed ID: 1277732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial pharmacology and toxicology of intravenous desmethylmisonidazole.
    Coleman CN; Wasserman TH; Phillips TL; Strong JM; Urtasun RC; Schwade JG; Johnson RJ; Zagars G
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):371-5. PubMed ID: 7107354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I study of the hypoxic cell radiosensitizer Ro-03-8799.
    Roberts JT; Bleehen NM; Workman P; Walton MI
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1755-8. PubMed ID: 6480458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic studies using multiple administration of RO 03-8799, a 2-nitroimidazole radiosensitizer.
    Stratford MR; Minchinton AI; Hill SA; McNally NJ; Williams MV
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):469-71. PubMed ID: 7107368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.